Atorvastatin Calcium Tablet, Coated
Product Images NDC 71209-090

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71209-090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cadila Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorva-fig-1 (Atorva Fig1)

FDA Label Image

Atorva-fig-2 (Atorva Fig2)

FDA Label Image

Atorva-fig-3 (Atorva Fig3)

FDA Label Image

Atorvastatin-spl-strc (Atorvastatin Spl Strc)

FDA Label Image

Cont-label-500s-40mg.jpg (Cont Label 500s 40mg)

FDA Label Image

Cont-label-500s-80mg.jpg (Cont Label 500s 80mg)

FDA Label Image

Cont-label-90s-10mg.jpg (Cont Label 90s 10mg)

FDA Label Image

Cont-label-90s-20mg.jpg (Cont Label 90s 20mg)

FDA Label Image

Cont-label-90s-40mg.jpg (Cont Label 90s 40mg)

FDA Label Image

Cont-label-90s-80mg.jpg (Cont Label 90s 80mg)

FDA Label Image

Table-10.jpg (Table 10)

This text provides data on the effects of different doses of Atorvastatin on various lipid levels in a sample of patients. The placebo group had 12 participants, while the groups receiving Atorvastatin had 37 (10 mg), 13 (20 mg), and 14 (80 mg) participants respectively. The text also provides the mean difference (with confidence intervals) in triglyceride, Total-C, LDL-C, HDL-C, and non-HDL-C levels between each Atorvastatin group and the placebo group.*

FDA Label Image

Table-11 (Table 11)

FDA Label Image

Table-12 (Table 12)

FDA Label Image

Table-7 (Table 7)

FDA Label Image

Table-8 (Table 8)

FDA Label Image

Table-9 (Table 9)

Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.